| Literature DB >> 32235690 |
Haiquan Xu1, Yanzhi Guo1, Shijun Lu1, Yunqian Ma1, Xiuli Wang1, Liyun Zhao2, Junmao Sun1.
Abstract
Although potatoes are highly nutritious, many epidemiological studies have connected their consumption with abnormal lipids, diabetes, and hypertension. Steamed potato bread has recently become one of China's staple foods. A randomized controlled trial was designed to evaluate the effect of steamed potato bread consumption on Chinese adolescents. Four classes from a high school were randomly selected and assigned to the intervention group (two classes) or control group (two classes). The steamed wheat bread (100% raw wheat flour) and potato bread (raw wheat flour to cooked potato flour ratio of 3:7) were provided to the control group and intervention group as staple food once a school day for 8 weeks, respectively. Compared with the control group, the intervention group had significant net changes in systolic blood pressure (4.6 mmHg, p = 0.010), insulin (-4.35 mIU/L, p < 0.001), total cholesterol (-0.13 mmol/L, p = 0.032), and high-density lipoproteins cholesterol (-0.07 mmol/L, p = 0.010). The urinary level of Na+/K+ did not differ between the groups. In conclusion, the intake of steamed potato bread for 8 weeks resulted in positive effects on the total cholesterol and insulin profiles but a negative effect on the systolic blood pressure and high-density lipoproteins cholesterol of adolescents.Entities:
Keywords: glucose; insulin; lipids; potato bread; urinary Na+/K+
Year: 2020 PMID: 32235690 PMCID: PMC7143724 DOI: 10.3390/ijerph17062096
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The CONSORT flowchart of the study.
Nutritional content of two types of steamed bread (100 g).
| Nutrients | Wheat Bread | Potato Bread |
|---|---|---|
| Energy (kcal) | 221.1 | 201.0 |
| Water (g) | 45.7 | 49.7 |
| Protein (g) | 7.5 | 6.7 |
| Fat (g) | 1.1 | 1.0 |
| Carbohydrate (g) | 43.9 | 39.5 |
| Fiber (g) | 1.36 | 2.39 |
| Vitamin C (mg) | <0.044 | <0.044 |
| β-Carotene (μg) | <2.00 | <2.00 |
| Vitamin E (mg) | 0.387 | 0.266 |
| Vitamin B1 (mg) | 0.02 | 0.10 |
| Vitamin B2 (mg) | 0.01 | 0.03 |
| Ash (g) | 0.44 | 0.74 |
| Sodium (mg) | 74.07 | 81.36 |
| Potassium (mg) | 61.34 | 159.48 |
| Calcium (mg) | 11.88 | 12.27 |
| Iron (mg) | 0.60 | 0.71 |
Characteristics of participants at baseline.
| Characteristics | Control Group | Intervention Group |
|---|---|---|
| Total ( | 58 | 65 |
| Sex ( | ||
| Boys | 23 (39.0) | 45 (69.2) ** |
| Girls | 36 (61.0) | 20 (30.8) |
| Nation ( | ||
| Han people | 54 (94.7) | 61 (95.3) |
| Minority | 3 (5.3) | 3 (4.7) |
| Menarche/spermorrhea ( | ||
| Yes | 56 (94.9) | 57 (87.7) |
| No | 3 (5.1) | 8 (12.3) |
| Age (year, Mean (SD)) † | 16.2 (0.5) | 16.4 (0.6) |
| Height (cm, Mean (SD)) † | 161.5 (7.8) | 168.3 (7.9) * |
| Weight (kg, Mean (SD)) † | 53.3 (8.2) | 60.5 (11.9) * |
| BMI (kg/m2, Mean (SD)) | 20.4 (2.5) | 21.2 (3.4) |
| Bread intake (g/day, Mean (SD)) † | 119.4 (47.3) | 160.8 (70.1) * |
| Energy provided by bread (kcal/day, Mean (SD)) † | 264.0 (104.6) | 323.3 (140.9) * |
** p < 0.01. * p < 0.05. # Comparison by chi-square test. † Comparison by t test. BMI: body mass index.
Nutrients provided by the steamed breads daily (Mean ± SD).
| Nutrients | Control Group | Intervention Group | |
|---|---|---|---|
| Energy (kcal) | 264.0 (104.6) | 323.3 (140.9) | 0.003 |
| Protein (g) | 8.9 ± 3.5 | 10.8 ± 4.4 | 0.005 |
| Fat (g) | 1.3 ± 0.5 | 1.6 ± 0.7 | 0.003 |
| Carbohydrate (g) | 52.3 ± 20.4 | 64.0 ± 25.7 | 0.004 |
| Fiber (g) | 1.62 ± 0.63 | 3.87 ± 1.55 | <0.001 |
| Vitamin E (mg) | 0.46 ± 0.18 | 0.43 ± 0.17 | 0.317 |
| Vitamin B1 (mg) | 0.02 ± 0.01 | 0.16 ± 0.07 | <0.001 |
| Vitamin B2 (mg) | 0.01 ± 0 | 0.05 ± 0.02 | <0.001 |
| Sodium (mg) | 88.32 ± 34.44 | 131.71 ± 52.92 | <0.001 |
| Potassium (mg) | 73.14 ± 28.52 | 258.18 ± 103.74 | <0.001 |
| Calcium (mg) | 14.16 ± 5.52 | 19.86 ± 7.98 | <0.001 |
| Iron (mg) | 0.72 ± 0.28 | 1.15 ± 0.46 | <0.001 |
The t test was used for the comparison between groups.
Outcomes of the intervention for groups and subgroups.
| Subgroups | Variables | Control Group | Intervention Group | Effect | |||
|---|---|---|---|---|---|---|---|
| Baseline | Changes | Baseline | Changes | Beta (95% CI) | |||
|
| Weight (kg) | 53.3 ± 8.2 | 1.9 ± 1.4 ** | 60.5 ± 12.1 | 1.9 ± 2.0 ** | 0.1 (−0.6, 0.7) | 0.831 |
| Height (cm) | 161.5 ± 7.8 | 1.8 ± 0.8 ** | 168.3 ± 8.0 | 1.7 ± 1.1 ** | 0 (−0.4, 0.3) | 0.858 | |
| BMI (kg/m2) | 20.4 ± 2.5 | 0.3 ± 0.6 ** | 21.2 ± 3.4 | 0.2 ± 0.8 * | 0 (−0.3, 0.2) | 0.738 | |
| SBP (mmHg) | 119.6 ± 9.3 | −0.5 ± 0.3 | 118.8 ± 8.9 | 4.2 ± 8.8 ** | 4.6 (1.1, 8.0) | 0.010 | |
| DBP (mmHg) | 75.6 ± 8.0 | −1.9 ± 8.7 | 77.4 ± 9.2 | −3.2 ± 9.2 ** | −1.3 (−4.6, 2.0) | 0.431 | |
| GLU (mmol/L) | 4.45 ± 0.3 | 0.53 ± 0.28 ** | 4.40 ± 0.37 | 0.46 ± 0.36 ** | −0.07 (−0.19, 0.04) | 0.215 | |
| INS (mIU/L) | 11.38 ± 3.1 | −0.46 ± 3.00 | 14.31 ± 4.34 | −4.68 ± 2.98 ** | −4.35 (−5.31, −3.14) | <0.001 | |
| CHO (mmol/L) | 3.42 ± 0.55 | 0.29 ± 0.33 ** | 3.39 ± 0.49 | 0.16 ± 0.35 ** | −0.13 (−0.26, −0.01) | 0.032 | |
| HDL-c (mmol/L) | 1.32 ± 0.26 | 0.00 ± 0.16 | 1.24 ± 0.25 | −0.07 ± 0.14 ** | −0.07 (−0.13, −0.02) | 0.010 | |
| LDL-c (mmol/L) | 1.70 ± 0.5 | 0.08 ± 0.43 | 1.75 ± 0.42 | −0.02 ± 0.23 ** | −0.10 (−0.23, 0.03) | 0.132 | |
| TG (mmol/L) | 0.78 ± 0.25 | 0.0 ± 0.24 | 0.82 ± 0.28 | 0.06 ± 0.27 | 0.06 (−0.03, 0.15) | 0.198 | |
| Urinary Na+ (mmol/L) | 150.6 ± 70.3 | 26.6 ± 89.7 * | 187.6 ± 80.4 | 22.5 ± 87.2 | −4.2 (−38.3, 30.0) | 0.809 | |
| Urinary K+ (mmol/L) | 21.6 ± 17.6 | 1.0 ± 22.2 | 26.6 ± 17.5 | −0.7 ± 20.8 | −1.7 (−10.0, 6.6) | 0.689 | |
| Urinary NA+/K+ | 9.4 ± 4.4 | 1.5 ± 6.0 | 8.7 ± 3.9 | 1.9 ± 5.7 * | 0.5 (−1.8, 2.7) | 0.687 | |
|
| Weight (kg) | 59.0 ± 9.4 | 1.4 ± 1.4 ** | 63.7 ± 12.8 | 1.8 ± 2.0 ** | 0.3 (−0.6, 1.3) | 0.478 |
| Height (cm) | 169.4 ± 4.8 | 2.0 ± 0.9 ** | 171.7 ± 6.7 | 2.0 ± 1.2 ** | 0 (−0.6, 0.6) | 0.959 | |
| BMI (kg/m2) | 20.6 ± 3.2 | 0 ± 0.5 | 21.6 ± 3.9 | 0.1 ± 0.8 | 0.1 (−0.3, 0.4) | 0.660 | |
| SBP (mmHg) | 120.7 ± 8.4 | −0.4 ± 9.7 | 120.3 ± 7.3 | 4.5 ± 9.1 * | 4.9 (0, 9.8) | 0.049 | |
| DBP (mmHg) | 74.4 ± 8.6 | −3.3 ± 8.9 | 76.8 ± 9.5 | −1.9 ± 9.8 | 1.4 (−3.6, 6.4) | 0.580 | |
| GLU (mmol/L) | 4.36 ± 0.29 | 0.72 ± 0.30 ** | 4.42 ± 0.4 | 0.41 ± 0.37 ** | −0.31 (−0.49, −0.13) | 0.001 | |
| INS (mIU/L) | 10.02 ± 1.91 | 0.71 ± 2.46 | 14.96 ± 4.89 | −5.25 ± 2.88 ** | −5.95 (−7.39, −4.51) | <0.001 | |
| CHO (mmol/L) | 3.10 ± 0.56 | 0.40 ± 0.23 ** | 3.29 ± 0.44 | 0.12 ± 0.32 * | −0.28 (−0.43, −0.13) | <0.001 | |
| HDL-c(mmol/L) | 1.23 ± 0.23 | 0.05 ± 0.15 | 1.15 ± 0.2 | −0.08 ± 0.13 ** | −0.13 (−0.2, −0.05) | 0.001 | |
| LDL-c(mmol/L) | 1.47 ± 0.54 | 0.21 ± 0.29 | 1.70 ± 0.39 | −0.03 ± 0.22 ** | −0.24 (−0.37, −0.11) | <0.001 | |
| TG (mmol/L) | 0.75 ± 0.24 | −0.05 ± 0.21 | 0.89 ± 0.28 | 0 ± 0.22 | 0.05 (−0.06, 0.17) | 0.338 | |
| Urinary Na+ (mmol/L) | 139.8 ± 57.3 | 45.1 ± 78.9 * | 189.6 ± 80.4 | 21.0 ± 86.1 | −24.1 (−68.2, 19.9) | 0.278 | |
| Urinary K+ (mmol/L) | 20.2 ± 16.2 | 1.9 ± 24.5 | 27.3 ± 18.9 | −2.5 ± 19.5 | −4.4 (−15.6, 6.8) | 0.436 | |
| Urinary NA+/K+ | 9.0 ± 4.1 | 1.9 ± 5.1 | 8.8 ± 4.0 | 2.1 ± 5.2 * | 0.2 (−2.5, 2.9) | 0.896 | |
|
| Weight (kg) | 49.8 ± 4.9 | 2.1 ± 1.4 ** | 53.5 ± 6.4 | 2.3 ± 2.2 ** | 0.1 (−1, 1.3) | 0.787 |
| Height (cm) | 156.7 ± 4.8 | 1.6 ± 0.8 ** | 161.0 ± 5.2 | 1.3 ± 0.7 ** | −0.4 (−0.8, 0.1) | 0.087 | |
| BMI (kg/m2) | 20.3 ± 2.0 | 0.4 ± 0.5 ** | 20.6 ± 2.1 | 0.5 ± 0.8 ** | 0.1 (−0.3, 0.5) | 0.663 | |
| SBP (mmHg) | 118.9 ± 9.9 | −0.3 ± 10.7 | 115.6 ± 11.3 | 3.6 ± 8.5 | 3.9 (−1.7, 9.5) | 0.168 | |
| DBP (mmHg) | 76.4 ± 7.6 | −0.9 ± 8.6 | 78.7 ± 8.8 | −5.7 ± 7.6 ** | −4.8 (−9.4, −0.1) | 0.044 | |
| GLU (mmol/L) | 4.50 ± 0.30 | 0.41 ± 0.20 ** | 4.36 ± 0.29 | 0.57 ± 0.33 ** | 0.15 (−0.01, 0.32) | 0.069 | |
| INS (mIU/L) | 12.27 ± 3.42 | −1.21 ± 3.10 * | 12.84 ± 2.19 | −3.47 ± 2.90 ** | −2.26 (−3.98, −0.55) | 0.010 | |
| CHO (mmol/L) | 3.64 ± 0.43 | 0.22 ± 0.36 ** | 3.61 ± 0.54 | 0.24 ± 0.41 * | 0.02 (−0.2, 0.23) | 0.882 | |
| HDL-c (mmol/L) | 1.38 ± 0.27 | −0.03 ± 0.15 | 1.44 ± 0.24 | −0.06 ± 0.16 | −0.03 (−0.11, 0.06) | 0.540 | |
| LDL-c (mmol/L) | 1.84 ± 0.42 | −0.01 ± 0.48 | 1.87 ± 0.45 | 0 ± 0.26 | 0.01 (−0.22, 0.25) | 0.909 | |
| TG (mmol/L) | 0.79 ± 0.26 | 0.03 ± 0.26 | 0.67 ± 0.23 | 0.17 ± 0.32* | 0.15 (−0.01, 0.31) | 0.071 | |
| Urinary Na+ (mmol/L) | 157.8 ± 77.7 | 11.6 ± 96.5 | 182.3 ± 82.7 | 26.7 ± 93.2 | 15.1 (−46.9, 77.2) | 0.624 | |
| Urinary K+ (mmol/L) | 22.5 ± 18.6 | 0.3 ± 20.7 | 24.9 ± 13.4 | 4.4 ± 24.1 | 4.1 (−10.1, 18.4) | 0.561 | |
| Urinary NA+/K+ | 9.7 ± 4.6 | 1.1 ± 6.8 | 8.5 ± 3.6 | 1.5 ± 7.3 | 0.4 (−4.1, 4.9) | 0.864 | |
The linear growth model was used for the comparison between groups. The comparison of overall participants was adjusted for sex. The t test was used for comparison within-group; ** p < 0.01; * p < 0.05. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; GLU: serum glucose; INS: serum insulin; CHO: total cholesterol; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; TG: triglycerides.
Figure 2The significant intervention effects (β) in two groups: (a) SBP, (b) CHO, (c) INS and (d) HDL-c.